{"id":"adimrsc-2f","_chembl":{"chemblId":"CHEMBL5878165","moleculeType":null,"molecularWeight":"419.86"},"_dailymed":null,"_scrapedAt":"2026-03-28T05:49:52.400Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T10:32:02.183591+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT05104489","phase":"PHASE1, PHASE2","title":"Dose-finding Study for AdimrSC-2f Vaccine","status":"COMPLETED","sponsor":"Adimmune Corporation","startDate":"2022-01-03","conditions":"COVID-19","enrollment":241},{"nctId":"NCT04522089","phase":"PHASE1","title":"A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine","status":"COMPLETED","sponsor":"Adimmune Corporation","startDate":"2020-08-24","conditions":"COVID-19","enrollment":68}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AdimrSC-2f","genericName":"AdimrSC-2f","companyName":"Adimmune Corporation","companyId":"adimmune-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T10:32:02.183591+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}